Termination of domestic licensing agreements for six anti-HIV drugs
This item covers the termination of the exclusive license agreement for the development and commercialization in Japan of 6 anti-HIV drugs, as well as the completed transfer of the marketing approvals.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.